January 08, 2021

These are the facts

Ugly single-source Nanox.Arc
Ugly
source:  RSNA2020 live demo


  1. Nanox has not submitted anything for FDA approval.

  2. It is illegal to market a Class II MEDICAL device, such as an x-ray diagnostic system, in the United States without clearance (or De Novo grant) pending (there are limited exceptions, but they don't apply here).

  3. Nanox now claims to have submitted an x-ray system for FDA clearance in January 2020 and that it does not intend to ever market that system. That "system" is very ugly, and is completely different from what Nanox has been showing in its investor presentations. The one shown in investor presentations has not been submitted for clearance, approval, or De Novo grant. There are reasons to believe that Nanox did not submit anything for clearance in January 2020, or, if a submission happened, it was fraudulent.

These are the facts. They are indisputable.
Fake (notice the XANON label) source:  November 2020 Investor Presentation, Slide 3
Fake (notice the XANON label)
source:  November 2020 Investor Presentation, Slide 3 


Update April 5, 2021:  Nanox got clearance, not approval, for a Nanox.Cart (the ugly device).

No comments:

Post a Comment